Clinical Trial Update: A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab in patients with advanced gynecologic clear cell cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Tumor
• Gynecologic Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University College, London | Conditions: Clear Cell Tumor, Gynecologic Cancer | Phase 2 | Status: UNKNOWN